Julian Mall
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Julian Mall has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ali Abdul Nabi Ali
Institute of Pathology, Clinics of the Region Hannover Hanover Germany
1 shared publication - Clara Boeker
Department of General, Visceral, Vascular and Bariatric Surgery, Klinikum Nordstadt, Haltenhoffstr. 41, 30167, Hannover, Germany.
1 shared publication - Ludwig Wilkens
Department of Pathology, Nordstadt Hospital Hannover, 30167 Hannover, Germany
1 shared publication - Moritz Rust
Institute of Pathology, Clinics of the Region Hannover Hanover Germany
1 shared publication - Nabih Farkouh
Institute of Pathology, Clinics of the Region Hannover Hanover Germany
1 shared publication - Piet Erik Beusker
Department of Pediatrics, Medical School and University Medical Center OWL, Protestant Hospital of the Bethel Foundation Bielefeld University Bielefeld Germany
1 shared publication
Latest Publications
- Open Access
- 7 January 2026
- Published by Wiley in Histopathology
- Vol. 88 (6) , 1250-1267
Optimized workup of lymph nodes in regard to UICC classification of colorectal carcinoma
Aims: Treatment and outcomes in colorectal carcinoma (CRC) depend on the UICC classification, depth of invasion, and distant metastases. However, it is not clear whether an extensive workup of lymph nodes (LNs) is important for the adequate determination of metastases. Therefore, we compared the number of LNs and metastases obtained by a standard protocol (SP) and an extended protocol (EP) in two series with a total of 105 CRC cases and 2417 LNs. Methods and results: In the first series, the EP included complete stepwise sectioning of all LN‐bearing paraffin blocks in each case, increasing the total number of LNs from 1247 in the SP to 1333 in the EP and the number of metastases from 69 to 80. One pTNM pN1a case became pN1b, and two pN1b cases became pN2a. The staging, and thus the therapy, changed in none of them. Furthermore, no relevant effect of embedding one versus both halves of large LNs >5 mm was evident. In the second series, the EP included immunohistochemical staining for pan‐cytokeratin (monoclonal antibodies AE1/AE3) of all LN‐bearing paraffin blocks in a given case. The number of detected metastases rose from 82 to 89, with a constant total 1084 LNs. In two cases, the pTNM classification changed from pN2a to pN2b. Staging and therapy changed in none. Conclusion: An extensive workup of LNs is not mandatory in patients with CRC. A straightforward protocol is sufficient to guide clinicians to the appropriate therapy.
- 7 January 2026
- Published by Wiley in Histopathology
- Vol. 88 (6) , 1250-1267
Open AccessOptimized workup of lymph nodes in regard to UICC classification of colorectal carcinoma
Aims: Treatment and outcomes in colorectal carcinoma (CRC) depend on the UICC classification, depth of invasion, and distant metastases. However, it is not clear whether an extensive workup of lymph nodes (LNs) is important for the adequate determination of metastases. Therefore, we compared the number of LNs and metastases obtained by a standard protocol (SP) and an extended protocol (EP) in two series with a total of 105 CRC cases and 2417 LNs. Methods and results: In the first series, the EP included complete stepwise sectioning of all LN‐bearing paraffin blocks in each case, increasing the total number of LNs from 1247 in the SP to 1333 in the EP and the number of metastases from 69 to 80. One pTNM pN1a case became pN1b, and two pN1b cases became pN2a. The staging, and thus the therapy, changed in none of them. Furthermore, no relevant effect of embedding one versus both halves of large LNs >5 mm was evident. In the second series, the EP included immunohistochemical staining for pan‐cytokeratin (monoclonal antibodies AE1/AE3) of all LN‐bearing paraffin blocks in a given case. The number of detected metastases rose from 82 to 89, with a constant total 1084 LNs. In two cases, the pTNM classification changed from pN2a to pN2b. Staging and therapy changed in none. Conclusion: An extensive workup of LNs is not mandatory in patients with CRC. A straightforward protocol is sufficient to guide clinicians to the appropriate therapy.